Assessing the quality of health care delivery has long interested ophthalmologists and guides discussions about informed consent, but with the increased use of electronic health records and the increased scrutiny by payers, more efforts have been devoted to the topic. Measuring quality is difficult, in part, because of the problem of defining benchmarks.1 In this context, the study by Jackson and colleagues2 on outcomes of vitreoretinal surgery for complications of proliferative diabetic retinopathy deserves attention.
Browning DJ. Vitrectomy for Proliferative Diabetic RetinopathyDoes Anyone Know the Complication Rate?. JAMA Ophthalmol. 2016;134(1):86-87. doi:10.1001/jamaophthalmol.2015.4597